  |
 |
 |
 |
 |
 |
|
HYPERSORB™
HyperSorb is a new, patented delivery system designed for efficacy, flexibility, and utility. Hypersorb represents a breakthrough in the lipid-based fill of soft gelatin and two-piece hard shell capsules. This technology incorporates active ingredients into a self-emulsifying liquid complex that is then enrobed into a capsule for convenient oral administration. This new system has a broad spectrum of applications and can limit the complexity of manufacturing. HyperSorbs has been proven to enhance the absorption of orally administered vitamins and nutritional ingredients. HyperSorb has a distinct advantage in ease of development, scale-up, and manufacturing compared to other controlled delivery technologies. This delivery system is especially suited for oral delivery of drugs with poor bioavailability such as newly discovered drugs, proteins and peptides that are not soluble with conventional technologies. Additionally, HyperSorb can also be used with drugs, proteins, hormones, and nutrients that cannot be absorbed from the GI tract and are given by an invasive route of administration such as injection or nasal inhalation, for example calcitonin, insulin, erythropoietin, morphine and vitamin B12.
The complex containing your drug or active ingredient can be taken orally, or used with various routes of administration including: rectal, vaginal, intra-oral, or as a unit-of-use container for topical administration. The HyperSorb Advantage
HyperSorb is one of the most significant developments in oral pharmaceutics within the last decade. Explore this robust platform for your existing and future oral delivery needs. Contents Copyright © 2004, BioZone Laboratories, Inc. all rights reserved |
